학술논문
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study
Document Type
Article
Author
PIGNOT, Géraldine; FENDLER, Jean Philippe; GUY, Laurent; VERHOEST, Grégory; MOTTET, Nicolas; DOERFLER, Arnaud; ABADIE LACOURTOISIE, Sophie; AZZOUZI, Abde Rahmene; MONGIAT, Pierre; GEOFFROIS, Lionnel; ESCHWEGE, Pascal; DI FIORE, Frédéric; ROUBAUD, Guilhem; HOEPFFNER, Jean Luc; BARTHELEMY, Philippe; LANG, Hervé; VOOG, Eric; MANDRON, Eric; TOURANI, Jean Marc; SERRATE, Camille; COLAU, Alexandre; SALDANA, Carolina; DE LA TAILLE, Alexandre; NGUYEN, Thierry; KLEINCLAUSS, François; LORIOT, Yohan; IRANI, Jacques; EYMARD, Jean Christophe; LARRE, Stéphane; HUILLARD, Olivier; ZERBIB, Marc; ROLLAND, Frédéric; RIGAUD, Jérôme; HOUEDE, Nadine; DROUPY, Stéphane; MALOUF, Georgina; ROUPRET, Morgan; VIEILLOT, Sabine; LETANG, Nicolas; LHARIDON, Tiffen; GASCHIGNARD, Nicolas; HILGERS, Werner; DAVIN, Jean Louis; Pfister, Christian ; Gravis, Gwenaelle; Flechon, Aude; Chevreau, Christine; Mahammedi, Hakim; Laguerre, Brigitte; Guillot, Aline; Joly, Florence; Soulie, Michel; Allory, Yves; Harter, Valentin; Culine, Stéphane
Source
In The Lancet Oncology February 2024 25(2):255-264
Subject
Language
ISSN
1470-2045